feed,title,long_url,short_url
SeekingAlpha,Xenon Pharmaceuticals: Upcoming Phase Two Major Depressive Disorder Data Readout Represents An Opportunity,https://seekingalpha.com/article/4647966,
SeekingAlpha,CDT Insider Sentiment Ratio October 2023: Low Sentiment-High Risk,https://seekingalpha.com/article/4647915,
SeekingAlpha,Wall Street Breakfast: Caught Short?,https://seekingalpha.com/article/4647965,
